 Actinium Pharmaceuticals, Inc. NYSE AMERICAN: ATNM Actinium or the Company today announced the closing of its previously announced public offering of 76,923,077 shares of its common stock or common stock equivalents in lieu thereof at a price to the public of 0.325 per share of common stock or common stock equivalent. The aggregate gross proceeds from this offering are approximately 25.0 million, before deducting placement agent fees and other estimated offering expenses payable by Actinium. 